↓ Skip to main content

Dove Medical Press

Article Metrics

Embed badge What is this page?

Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review

Overview of attention for article published in International Journal of Nephrology and Renovascular Disease, December 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
8 Mendeley

What is this page?

Summary Twitter Dimensions citations
Title
Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review
Published in
International Journal of Nephrology and Renovascular Disease, December 2012
DOI 10.2147/ijnrd.s28159
Pubmed ID
23293535
Authors

Joanne Foody, Naderi

Abstract

The majority of chronic kidney disease patients die of cardiovascular disease prior to reaching end-stage renal disease. The combination of ezetimibe and a statin has been the focus of a number of recent studies, given initial data showing a substantial reduction in low- density lipoprotein with the addition of ezetimibe. However, it is unclear how this low-density lipoprotein reduction impacts cardiovascular disease outcomes. This review will briefly discuss the burden of cardiovascular disease and the pathophysiology of dyslipidemia in chronic kidney disease patients. It will then assess the data regarding the impact of adding ezetimibe to a statin on the general population, and specifically predialysis chronic kidney disease patients.

View on publisher site

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 13%
Unknown 7 88%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Medicine and Dentistry 1 13%
Unknown 6 75%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2012.
All research outputs
#3,549,064
of 4,507,211 outputs
Outputs from International Journal of Nephrology and Renovascular Disease
#46
of 71 outputs
Outputs of similar age
#227,997
of 282,931 outputs
Outputs of similar age from International Journal of Nephrology and Renovascular Disease
#3
of 5 outputs
Altmetric has tracked 4,507,211 research outputs across all sources so far. This one is in the 3rd percentile – i.e., 3% of other outputs scored the same or lower than it.
So far Altmetric has tracked 71 research outputs from this source. They receive a mean Attention Score of 1.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 282,931 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.

This page is hosted by Altmetric on behalf of Dove Medical Press.